230 related articles for article (PubMed ID: 21790828)
1. Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.
Avril T; Vauleon E; Hamlat A; Saikali S; Etcheverry A; Delmas C; Diabira S; Mosser J; Quillien V
Brain Pathol; 2012 Mar; 22(2):159-74. PubMed ID: 21790828
[TBL] [Abstract][Full Text] [Related]
2. Image-based assessment of natural killer cell activity against glioblastoma stem cells.
Du Y; Metcalfe S; Akunapuram S; Ghosh S; Spruck C; Richardson AM; Cohen-Gadol AA; Shen J
FEBS Open Bio; 2024 Jun; 14(6):1028-1034. PubMed ID: 38740554
[TBL] [Abstract][Full Text] [Related]
3. PNIPAAm-co-Jeffamine
Heffernan JM; McNamara JB; Borwege S; Vernon BL; Sanai N; Mehta S; Sirianni RW
Biomaterials; 2017 Oct; 143():149-158. PubMed ID: 28802102
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.
Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB
Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984
[TBL] [Abstract][Full Text] [Related]
5. Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells.
Baugh R; Khalique H; Page E; Lei-Rossmann J; Wan PK; Johanssen T; Ebner D; Ansorge O; Seymour LW
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38724464
[TBL] [Abstract][Full Text] [Related]
6. Modelling glioblastoma tumour-host cell interactions using adult brain organotypic slice co-culture.
Marques-Torrejon MA; Gangoso E; Pollard SM
Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29196443
[TBL] [Abstract][Full Text] [Related]
7. UTX inhibition suppresses proliferation and promotes apoptosis in patient-derived glioblastoma stem cells by modulating periostin expression.
Luan Y; Zhang H; Liu Y; Xue J; Wang K; Ma B; Ma K; Lu H; Chen X; Liu Y; Zhang Z
J Cell Physiol; 2024 Apr; 239(4):e31178. PubMed ID: 38214211
[TBL] [Abstract][Full Text] [Related]
8. Ribosomal protein S6 promotes stem-like characters in glioma cells.
Shirakawa Y; Hide T; Yamaoka M; Ito Y; Ito N; Ohta K; Shinojima N; Mukasa A; Saito H; Jono H
Cancer Sci; 2020 Jun; 111(6):2041-2051. PubMed ID: 32246865
[TBL] [Abstract][Full Text] [Related]
9. Identification of glioblastoma stem cell-associated lncRNAs using single-cell RNA sequencing datasets.
Hazra R; Utama R; Naik P; Dobin A; Spector DL
Stem Cell Reports; 2023 Nov; 18(11):2056-2070. PubMed ID: 37922916
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells.
Kardani K; Sanchez Gil J; Rabkin SD
Front Cell Infect Microbiol; 2023; 13():1206111. PubMed ID: 37325516
[TBL] [Abstract][Full Text] [Related]
11. Stationary-to-migratory transition in glioblastoma stem-like cells driven by a fatty acid-binding protein 7-RXRα neurogenic pathway.
Liu RZ; Choi WS; Jain S; Xu X; Elsherbiny ME; Glubrecht DD; Tessier AG; Easaw JC; Fallone BG; Godbout R
Neuro Oncol; 2023 Dec; 25(12):2177-2190. PubMed ID: 37499046
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional model of glioblastoma by co-culturing tumor stem cells with human brain organoids.
Azzarelli R; Ori M; Philpott A; Simons BD
Biol Open; 2021 Feb; 10(2):. PubMed ID: 33619017
[TBL] [Abstract][Full Text] [Related]
13. CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma.
Nakazawa T; Morimoto T; Maeoka R; Matsuda R; Nakamura M; Nishimura F; Ouji N; Yamada S; Nakagawa I; Park YS; Ito T; Nakase H; Tsujimura T
J Exp Clin Cancer Res; 2023 Aug; 42(1):205. PubMed ID: 37563692
[TBL] [Abstract][Full Text] [Related]
14. Matrix Hyaluronic Acid and Hypoxia Influence a CD133
Chen JE; Leary S; Barnhouse V; Sarkaria JN; Harley BAC
Tissue Eng Part A; 2022 Apr; 28(7-8):330-340. PubMed ID: 34435883
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Methods for the Study of Glioblastoma Stem-Like Cell Radiosensitivity.
McAbee JH; Degorre-Kerbaul C; Tofilon PJ
Methods Mol Biol; 2021; 2269():37-47. PubMed ID: 33687670
[TBL] [Abstract][Full Text] [Related]
16. Image-Based Assessment of Natural Killer Cell Activity against Glioblastoma Stem Cells.
Du Y; Metcalfe S; Akunapuram S; Richardson AM; Cohen-Gadol AA; Shen J
bioRxiv; 2023 Dec; ():. PubMed ID: 38234778
[TBL] [Abstract][Full Text] [Related]
17. Unlocking Glioblastoma Secrets: Natural Killer Cell Therapy against Cancer Stem Cells.
Du Y; Pollok KE; Shen J
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136381
[TBL] [Abstract][Full Text] [Related]
18. Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in Glioblastoma.
Castellan M; Guarnieri A; Fujimura A; Zanconato F; Battilana G; Panciera T; Sladitschek HL; Contessotto P; Citron A; Grilli A; Romano O; Bicciato S; Fassan M; Porcù E; Rosato A; Cordenonsi M; Piccolo S
Nat Cancer; 2021 Feb; 2(2):174-188. PubMed ID: 33644767
[TBL] [Abstract][Full Text] [Related]
19. The Multi-Faceted Effect of Curcumin in Glioblastoma from Rescuing Cell Clearance to Autophagy-Independent Effects.
Ryskalin L; Biagioni F; Busceti CL; Lazzeri G; Frati A; Fornai F
Molecules; 2020 Oct; 25(20):. PubMed ID: 33092261
[TBL] [Abstract][Full Text] [Related]
20. Overcoming multidrug resistance by reversan and exterminating glioblastoma and glioblastoma stem cells by delivering drug-loaded nanostructure hybrid lipid capsules (nHLCs).
Hasan U; Chauhan M; Basu SM; R J; Giri J
Drug Deliv Transl Res; 2024 Feb; 14(2):342-359. PubMed ID: 37587289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
